Found: 17
Select item for more details and to access through your institution.
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 6, p. 462, doi. 10.1002/cyto.b.22099
- By:
- Publication type:
- Article
Immunophenotypic shift in the B‐cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B‐lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 434, doi. 10.1002/cyto.b.21951
- By:
- Publication type:
- Article
Eleven‐marker 10‐color flow cytometric assessment of measurable residual disease for T‐cell acute lymphoblastic leukemia using an approach of exclusion.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 4, p. 421, doi. 10.1002/cyto.b.21939
- By:
- Publication type:
- Article
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre‐myelomastocytic leukemia condition.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 331, doi. 10.1002/cyto.b.21938
- By:
- Publication type:
- Article
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 2, p. 206, doi. 10.1002/cyto.b.21943
- By:
- Publication type:
- Article
CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 4, p. 328, doi. 10.1002/cyto.b.21866
- By:
- Publication type:
- Article
A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10<sup>6</sup> and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 1, p. 57, doi. 10.1002/cyto.b.21831
- By:
- Publication type:
- Article
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 3, p. 509, doi. 10.1002/cyto.b.21619
- By:
- Publication type:
- Article
Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 100, doi. 10.1002/cyto.b.21486
- By:
- Publication type:
- Article
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 1, p. 122, doi. 10.1111/ejh.14102
- By:
- Publication type:
- Article
Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00577
- By:
- Publication type:
- Article
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B‐lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 374, doi. 10.1111/bjh.17801
- By:
- Publication type:
- Article
Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 6, p. 972, doi. 10.1111/ijlh.14117
- By:
- Publication type:
- Article
Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 5, p. 990, doi. 10.1111/ijlh.13456
- By:
- Publication type:
- Article
Over expression of brain and acute leukemia, cytoplasmic and ETS‐related gene is associated with poor outcome in acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 808, doi. 10.1002/hon.2800
- By:
- Publication type:
- Article
Improved protocol for plasma microRNA extraction and comparison of commercial kits.
- Published in:
- Biochemia Medica, 2021, v. 31, n. 3, p. 1, doi. 10.11613/BM.2021.030705
- By:
- Publication type:
- Article